E. Chapman

Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab

M. Kaminski, J. Leonard, K. Griffith, 2015, Leukemia & lymphoma.